Literature DB >> 2844905

Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication.

M Sarmiento1.   

Abstract

Macrophages isolated from mice resistant to acute (lethal) infection with a neurovirulent isolate of HSV-1 express intrinsic resistance to viral infection in vitro. Bone marrow (BM), spleen (S), peritoneal (P), and thioglycolate-stimulated peritoneal (Pthio) macrophages isolated from resistant C57BL/6 Cr (B6) mice consistently restrict HSV-1 macromolecular synthesis earlier in the viral replicative cycle than do macrophages isolated from the same tissue sources from more susceptible DBA/2Cr (D2) mice. B6-BM (BM macrophages from B6 mice) restrict HSV macromolecular synthesis at least at two points in the replicative cycle: 1) before the onset of alpha-protein synthesis and 2) between the onset of gamma 1 protein and DNA synthesis. D2-BM macrophages restrict HSV replication at about the time of DNA synthesis. B6-P macrophages restrict HSV replication shortly after gamma 1 protein synthesis, and D2-P macrophages inhibit the virus slightly later, but before DNA synthesis. B6-S macrophages restrict HSV replication at about the time of DNA synthesis, and D2-S macrophages inhibit replication after the onset of gamma 2 protein synthesis. Pthio macrophages are more permissive to HSV infection than BM, P, or S macrophages: restrictions in viral replication occur at the time of DNA synthesis in B6-Pthio macrophages, and after the onset of gamma 2 protein synthesis in D2-Pthio cells. These studies demonstrate that isolated macrophages from inbred mouse strains express intrinsic resistance to HSV infection that correlates with in vivo resistance to acute (lethal) infection. Intrinsic resistance to HSV-1 infection is due to restriction of viral macromolecular synthesis. HSV replication is inhibited in macrophages at multiple points in the viral growth cycle, depending on the tissue from which the cells are isolated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844905

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Recombinant interleukin-1 alpha, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1.

Authors:  C Berkowitz; Y Becker
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Interleukin-1 alpha gene-transcription in murine keratinocytes is inhibited by HSV-1 infection.

Authors:  C Enk; E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Induction of interleukin-1 alpha and beta gene transcription in mouse peritoneal exudate cells after intraperitoneal infection with herpes simplex virus-1.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Molecular localization of abortive infection of resident peritoneal macrophages by herpes simplex virus type 1.

Authors:  P S Morahan; S Mama; F Anaraki; K Leary
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 6.  Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.

Authors:  Mark A Brockman; David M Knipe
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

7.  The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice.

Authors:  R Kurachi; T Daikoku; T Tsurumi; K Maeno; Y Nishiyama; T Kurata
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Foot and mouth disease virus undergoes non-progressive replication in mice peritoneal macrophages and induces M1 polarization.

Authors:  Renjith Sebastian; M Sravanthi; V Umapathi; N Krishnaswamy; M Priyanka; H J Dechamma; K Ganesh; Suresh H Basagoudanavar; A Sanyal; G R Reddy
Journal:  Virus Res       Date:  2020-02-25       Impact factor: 3.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.